Embryology Text Books: Implications for Fetal Research Dianne N
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Twenty-Week Bans, New Medical Evidence, and the Effect on Current United States Supreme Court Abortion Law Precedent Shea Leigh Line
Idaho Law Review Volume 50 | Number 3 Article 5 October 2014 Twenty-Week Bans, New Medical Evidence, and the Effect on Current United States Supreme Court Abortion Law Precedent Shea Leigh Line Follow this and additional works at: https://digitalcommons.law.uidaho.edu/idaho-law-review Recommended Citation Shea L. Line, Twenty-Week Bans, New Medical Evidence, and the Effect on Current United States Supreme Court Abortion Law Precedent, 50 Idaho L. Rev. 139 (2014). Available at: https://digitalcommons.law.uidaho.edu/idaho-law-review/vol50/iss3/5 This Article is brought to you for free and open access by Digital Commons @ UIdaho Law. It has been accepted for inclusion in Idaho Law Review by an authorized editor of Digital Commons @ UIdaho Law. For more information, please contact [email protected]. TWENTY-WEEK BANS, NEW MEDICAL EVIDENCE, AND THE EFFECT ON CURRENT UNITED STATES SUPREME COURT ABORTION LAW PRECEDENT TABLE OF CONTENTS PART I: INTRODUCTION .................................................................. 140 PART II: ABORTION LAW PRECEDENT THROUGHOUT THE PAST FORTY YEARS: ROE V. WADE, PLANNED PARENTHOOD V. CASEY, & GONZALES V. CARHART ...... 143 A. Roe v. Wade ............................................................................. 144 B. Planned Parenthood v. Casey ................................................ 148 C. Gonzales v. Carhart ................................................................ 152 PART III: THE IMPACT OF CURRENT SUPREME COURT ABORTION LAW PRECEDENT ON THE STATES TWENTY-WEEK BANS ............................................................ -
EQUINE CONCEPTUS DEVELOPMENT – a MINI REVIEW Maria Gaivão 1, Tom Stout
Gaivão & Stout Equine conceptus development – a mini review EQUINE CONCEPTUS DEVELOPMENT – A MINI REVIEW DESENVOLVIMENTO DO CONCEPTO DE EQUINO – MINI REVISÃO Maria Gaivão 1, Tom Stout 2 1 - CICV – Faculdade de Medicina Veterinária; ULHT – Universidade Lusófona de Humanidades e Tecnologias; [email protected] 2 - Utrecht University, Department of Equine Sciences, Section of Reproduction, The Netherlands. Abstract: Many aspects of early embryonic development in the horse are unusual or unique; this is of scientific interest and, in some cases, considerable practical significance. During early development the number of different cell types increases rapidly and the organization of these increasingly differentiated cells becomes increasingly intricate as a result of various inter-related processes that occur step-wise or simultaneously in different parts of the conceptus (i.e., the embryo proper and its associated membranes and fluid). Equine conceptus development is of practical interest for many reasons. Most significantly, following a high rate of successful fertilization (71-96%) (Ball, 1988), as many as 30-40% of developing embryos fail to survive beyond the first two weeks of gestation (Ball, 1988), the time at which gastrulation begins. Indeed, despite considerable progress in the development of treatments for common causes of sub-fertility and of assisted reproductive techniques to enhance reproductive efficiency, the need to monitor and rebreed mares that lose a pregnancy or the failure to produce a foal, remain sources of considerable economic loss to the equine breeding industry. Of course, the potential causes of early embryonic death are numerous and varied (e.g. persistent mating induced endometritis, endometrial gland insufficiency, cervical incompetence, corpus luteum (CL) failure, chromosomal, genetic and other unknown factors (LeBlanc, 2004). -
Secretion and Immunolocalization of Retinol-Binding Protein in Bovine Conceptuses During Periattachment Periods of Early Pregnancy
Journal of Reproduction and Development, Vol. 48, No. 4, 2002 —Original— Secretion and Immunolocalization of Retinol-Binding Protein in Bovine Conceptuses during Periattachment Periods of Early Pregnancy Kaung Huei LIU1) 1)Department of Veterinary Science, National Chiayi University, Chiayi , Taiwan 300, Republic of China Abstract. The purpose of the study was to determine and compare the secretion of RBP by bovine spherical, elongating and filamentous conceptuses, and to identify the cellular location of RBP in developing conceptuses by immmunocytochemistry. Bovine conceptuses were removed from the uterus between days 13 and 22 of pregnancy. Events of early bovine embryonic development were observed. The conceptuses underwent a transformation from a spherical to a filamentous morphology during the periattachment period of placentation. Isolated conceptuses were cultured in a modified minimum essential medium in the presence of radiolabeled amino acids. Presence of retinol-binding protein (RBP) in culture medium was determined by immunoprecipitation using bovine placental anti-RBP serum. Presence of immunoreactive RBP in detectable quantities in spherical blastocyst (day 13) culture medium was evident. Increased amounts of RBP were clearly detected in cultures on days 14 and 15, the time of elongating conceptuses. RBP was abundant in cultures on day 22, when the conceptuses were filamentous. Cellular sources of RBP in day 15 and 22 conceptuses were determined by immunocytochemistry with anti-RBP serum. Strong immunoreactive RBP was localized in trophectoderm of day 15 conceptuses, and in epithelial cells lining the chorion and allantois of day 22 conceptuses. RBP originating from the conceptus may serve to transport retinol locally from the uterus to embryonic tissues. -
Virginia Commonwealth University Volunteer Doula Program Training Manual Kathleen M
Virginia Commonwealth University VCU Scholars Compass School of Nursing Publications School of Nursing 2015 Virginia Commonwealth University Volunteer Doula Program Training Manual Kathleen M. Bell Virginia Commonwealth University, [email protected] Susan L. Linder Virginia Commonwealth University, [email protected] Follow this and additional works at: http://scholarscompass.vcu.edu/nursing_pubs Part of the Maternal, Child Health and Neonatal Nursing Commons Copyright © 2015 The Authors Downloaded from http://scholarscompass.vcu.edu/nursing_pubs/16 This Curriculum Material is brought to you for free and open access by the School of Nursing at VCU Scholars Compass. It has been accepted for inclusion in School of Nursing Publications by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Virginia Commonwealth University Volunteer Doula Program Training Manual “Empowerment, advocacy and support for one of life’s greatest journeys.” 1 Reflection and Discussion Why are you here? Why did you decide to do this doula training? What experiences do you have with birth, and how have they shaped your desire to participate in this program? What does it mean to be a doula with the VCU School of Nursing? What other reflections do you have? 2 Table of Contents 1. An overview of birth: Statistics and trends………………page 4-6 2. Birth workers and their roles………………...……………pages 7-10 3. You are a doula! Your birth-bag and preparation………..pages 11-14 4. Anatomy and Physiology of birth………………………...pages 15-18 5. Hormonal regulation of labor and birth…………………..pages 19-21 6. Pharmacologic management of labor…………………….pages 22-26 7. -
When Does Human Life Begin? Christian Thinking and Contemporary Opposition
Salt&Light series When does human life begin? Christian thinking and contemporary opposition JOHN R LING Salt&Light series When does human life begin? Christian thinking and contemporary opposition JOHN R LING The substance of this booklet is an extract from The Morning-After Pill – Uncovering the Truth, published by The Christian Institute in 2007: http://www.christian.org.uk/resource/the-morning-after-pill Copyright © The Christian Institute 2017 The author has asserted his right under Section 77 of the Copyright, Designs & Patents Act 1988 to be identified as the author of this work. First printed in June 2011 Reprinted in May 2015 and August 2017 ISBN 978-1-901086-47-8 Published by The Christian Institute Wilberforce House, 4 Park Road, Gosforth Business Park, Newcastle upon Tyne, NE12 8DG All rights reserved No part of this publication may be reproduced, or stored in a retrieval system, or transmitted, in any form or by any means, mechanical, electronic, photocopying, recording or otherwise, without the prior permission of The Christian Institute. All scripture quotations, unless otherwise indicated, are taken from the HOLY BIBLE, NEW INTERNATIONAL VERSION®. NIV®. Copyright © 1973, 1978, 1984 by International Bible Society. Used by permission of Zondervan. All rights reserved. The Christian Institute is a Company Limited by Guarantee, registered in England as a charity. Company No. 263 4440, Charity No. 100 4774. A charity registered in Scotland. Charity No. SC039220 Contents 5 1 . Introduction 7 2 . The answer from the Bible 17 3 . The view of the early church 21 4 . The drift from the biblical worldview 25 5 . -
Ordering and Interpreting Screening and Diagnostic Tests: for Registered Midwives Standards, Limits, Conditions
BCCNM REGISTERED MIDWIVES Ordering and Interpreting Screening and Diagnostic Tests Standards, Limits, Conditions 900 – 200 Granville St T: 604.742.6200 Vancouver, BC V6C 1S4 Toll-free: 1.866.880.7101 Canada bccnm.ca Last Updated: February 2021 ORDERING AND INTERPRETING SCREENING AND DIAGNOSTIC TESTS: FOR REGISTERED MIDWIVES STANDARDS, LIMITS, CONDITIONS Revision Log Revision Date Revisions Made April 25, 2003 Published March 13, 2020 Updated February 2021 Applied BCCNM branding and updated references to CMBC BC COLLEGE OF NURSES AND MIDWIVES / 2 ORDERING AND INTERPRETING SCREENING AND DIAGNOSTIC TESTS: FOR REGISTERED MIDWIVES STANDARDS, LIMITS, CONDITIONS Table of Contents General Standards for Ordering and Interpreting Screening and Diagnostic Tests ................. 6 1.a A midwife may order, collect samples for and interpret the report of the following maternal screening and diagnostic tests: .............................................................................. 8 Actim Partus ......................................................................................................................................................................................8 Blood Glucose ................................................................................................................................................................................. 10 Blood Group and Type with Antibody Screen ................................................................................................................ 15 Cervical and Vaginal -
Pathology and Pregnancy Congratulations As Everyone Will Tell You, Having a Baby Is One of Life’S Most Amazing and Enriching Experiences
Pathology and Pregnancy Congratulations As everyone will tell you, having a baby is one of life’s most amazing and enriching experiences. Whether this is your first pregnancy or you’ve done it all before, pathology tests will play a vital role in your care and progress. Every pregnancy is different. As your pregnancy progresses and your baby develops, you can expect to have some relevant tests. This booklet sets out the tests and gives you information about what they tell us. Some will be a matter of routine and others may be suggested if your doctor or midwife thinks they are necessary. Some will be done regularly every few weeks, others only at certain times when your baby is at a particular developmental milestone. It’s our job to perform your tests. You are most likely to meet us through our caring and friendly blood collectors. Behind them, back in the lab, are our pathologists and scientists, the medical experts who do the testing and interpret the results. They help your doctor make the important decisions. All of us at Sullivan Nicolaides Pathology are part of your healthcare team, and we are with you every step of the way. We wish you a happy pregnancy and a safe delivery 2 TESTS DURING PREGNANCY Not all tests are routine; some may only be performed if indicated. TIMING TESTS First Trimester MOTHER’S HEALTH Pregnancy test Full blood count including haemoglobin and platelet count Blood group and antibody testing Iron studies Blood glucose Vitamin D level Urine test for glucose and protein Pap smear INFECTIOUS DISEASES Rubella (German -
Pregnancy Testing
PREGNANCY TESTING I. INTRODUCTION Early pregnancy testing has a number of benefits. A positive pregnancy test allows for early entry into prenatal services for those who wish to be pregnant or a discussion of options for those who do not wish to be pregnant. A negative pregnancy test provides the opportunity to discuss contraception for those who wish not to be pregnant or preconception counseling for those wishing to become pregnant. A number of different pregnancy tests are available. The most common office pregnancy tests are urine immunometric assays that are specific for the Beta subunit of human chorionic gonadotropin (-hCG). These tests provide accurate qualitative (positive or negative) test results for hCG levels from 5 to 50 mIU/mL. Most of these tests can detect pregnancy 7-10 days after conception and approximately 1 week before the next period is due. False-negative results can occur if the urine specimen is dilute or if the -hCG level is too low to be detected by that specific test. False-positive results can occur due to product or laboratory error or due to a cross-reaction of hCG with luteinizing hormone. Urine pregnancy tests do not quantitate the level of -hCG present. The immunometric tests for urinary -hCG are generally positive when the maternal serum levels of -hCG are 25 mIU/mL or more. After delivery or termination of pregnancy, -hCG levels decrease slowly. A - hCG level may be detected in the urine as long as 60 days (31-38 days usual range) after a first trimester abortion. As long as the -hCG levels are dropping this should not cause concern. -
Induced Abortions in Minnesota January - December 2018: Report to the Legislature
Induced Abortions in Minnesota January - December 2018: Report to the Legislature 07/01/2019 Induced Abortions in Minnesota January – December 2018 Report to the Legislature July 2019 Minnesota Department of Health Center for Health Statistics PO Box 64882 St. Paul, MN 55164-0882 651-201-5944 800-657-3900 [email protected] www.health.state.mn.us As requested by Minnesota Statute 3.197: This report cost approximately $4,000 to prepare, including staff time, printing and mailing expenses. Upon request, this material will be made available in an alternative format such as large print, Braille or audio recording. Printed on recycled paper. TABLE OF CONTENTS Introduction iii Technical Notes v Tables Table 1.1 Abortions by Month and Provider for Facilities 2 Table 1.2 Abortions by Month and Provider for Physicians 3 Table 2 Medical Specialty of Physician 6 Table 3 Type of Admission 6 Table 4 Age of Woman 7 Table 5 Marital Status of Woman 7 Table 6 Country/State Residence of Woman 8 Table 7 County of Residence for Women Residing in Minnesota 9 Table 8 Hispanic Ethnicity of Woman / Race of woman 10 Table 9 Race and Hispanic Ethnicity by Minnesota Residence 11 Table 10 Education Level of Woman 12 Table 11 Clinical Estimate of Fetal Gestational Age (grouped) 13 Table 11a Clinical Estimate of Fetal Gestational Age 14 Table 12 Prior Pregnancies 15 Table 13 Abortion Procedure 16 Table 14 Method of Disposal of Fetal Remains 17 Table 15 Payment Type and Health Insurance Coverage 18 Table 16 Reason for Abortion 19 Table 16a Other Stated Reason -
The History of Abortion
The History of Aboron Carole Joffe, PhD Professor, Bixby Center for Global Reproductive Health ! Abor%on as a Universal Phenomenon “There is every indication that abortion is an absolutely universal phenomenon, and that it is impossible even to construct an imaginary social system in which no woman would ever feel at least compelled to abort.” Devereux, A typological study of abortion in 350 primitive, ancient and pre- industrial societies, 1954. ! Early References to Abor%on SpeciCic (non-critical) references to abortion • One of earliest known medical texts, attributed to the Chinese emperor, Shen Nung, 2737-2698 B.C. • Ebers Papyrus of Egypt, 1550 B.C.-1500 B.C. • Various writers of Roman Empire: Ovid, Juvenal, Seneca, (1st century B.C., 1st and 2nd centuries A.D.) • Al-Rasi, Persian physician, 10th century Riddle, Contraception and Abortion from the Ancient World to the Renaissance, 1992. Himes, Medical History of Contraception, 1936. ! Hippocrates and Abor%on What did his oath actually say? • Translation A: “”Neither will I give a woman means to procure an abortion.” • Translation B: “Neither will I give a suppository to cause an abortion.” – i.e. Hippocrates only opposing one method of abortion Evidence supporting Translation B: “Works ascribed to Hippocrates describe a graduated set of dilators that could be used for abortions.” Joffe in Paul, et al., Management of Unintended and Abnormal Pregnancy, 2009. Riddle, Contraception and Abortion from the Ancient World to the Renaissance, 1992. ! 1950s and Beyond Gradual liberalization • China, most European countries; U.S. and Canada, India, S. Africa, Mexico City, Colombia • “menstrual extraction clinics” in Bangladesh and elsewhere ! 1950s and Beyond Gradual improvement in technology • vacuum aspiration – introduced in U.S. -
How Can Genetic Testing Help You with Your IVF Treatment?
How can genetic testing help you with your IVF treatment? In vitro fertilization, commonly referred to as IVF, is the assisted process of fertilization to help in the conception of a child. IVF utilizes a controlled laboratory environment that can significantly increase the chance of having a baby. With IVF, a sperm and egg are combined, to create an embryo that is incubated and carefully monitored as it begins to grow and develop over the next 5 to 6 days. Embryos that develop suc- cessfully can be transferred back into the uterus or frozen for a future transfer. About 10-12 days after an embryo transfer, the patient will take a pregnancy test. Table of contents Table Why should I start 01 IVF treatment p. 4 What is involved 02 in an IVF cycle? p. 6 Success 03 factors p. 17 Your IVF treatment journey and 04 genetic testing p. 21 About 05 Igenomix p. 35 01 Why should I start IVF treatment? INFERTILITY OTHER REASONS Female ovulation Genetic disorders disorders Blocked, damaged Carrier of genetic or removed disorder fallopian tubes Same sex couples Premature using gamete ovarian failure donors Male infertility Fertility Others preservation 4 In vitro fertilization is typically used when couples have been unable to conceive after trying other types of fertility treatments. IVF can be used to treat infertility caused by a number of reasons, including fema- le ovulation disorders; premature ovarian failure; blocked, damaged or removed fallo- pian tubes; and male infertility. IVF may also be useful for fertile indivi- duals seeking to pursue genetic testing of embryos, or PGT, for a hereditary disor- der, for same-sex couples who wish to use gamete donors, for individuals who re- quire a gestational carrier, or for fertility preservation. -
Chapter 38: Reproduction and Development Computer Test Bank Cryopreservation
Chapter 38 Organizer Reproduction and Development Refer to pages 4T-5T of the Teacher Guide for an explanation of the National Science Education Standards correlations. Teacher Classroom Resources Activities/FeaturesObjectivesSection MastersSection TransparenciesReproducible Reinforcement and Study Guide, pp. 167-168 L2 Section Focus Transparency 93 L1 ELL Section 38.1 1. Identify the parts of the male and Inside Story: Sex Cell Production, p. 1033 Section 38.1 female reproductive systems. Problem-Solving Lab 38-1, p. 1035 Concept Mapping, p. 38 L3 ELL Basic Concepts Transparency 74 L2 ELL Human Reproductive 2. Summarize the negative feedback Human Critical Thinking/Problem Solving, p. 38 L3 Basic Concepts Transparency 75 L2 ELL Systems control of reproductive hormones. Reproductive Content Mastery, pp. 185-186, 188 L1 Reteaching Skills Transparency 55 L1P ELL National Science Education 3. Sequence the stages of the menstrual Systems P P cycle. Standards UCP.1-3, UCP.5; P C.1, C.5; F.1 (2 sessions, 11/ P 2 Reinforcement and Study Guide, p. 169 L2 P Section Focus Transparency 94 L1 ELLP blocks) Section 38.2 P LS BioLab and MiniLab Worksheets, pp. 169-170 L2 Reteaching Skills Transparency 56a,P 56b L1 LS P LS Development Laboratory Manual, pp. 277-284 L2 ELL P Before Birth LS Section 38.2 4. Summarize the events during each MiniLab 38-1: Examining Sperm and Egg Content Mastery, pp. 185,LS 187-188 L1 LS P LS trimester of pregnancy. Attraction, p. 1038 LS Development Before MiniLab 38-2: Making a Graph of Fetal Size, P LS P Reinforcement and Study Guide, p.